PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Oct-2025 CD Bioparticles Launches Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research CD Bioparticles
17-Oct-2025 Manatee Acquires Happypillar to Scale Personalized Mental Health Care for Families ACCESS Newswire
17-Oct-2025 CD Bioparticles Introduces Custom Enzyme-Conjugated Particles Services for Advancement in Drug Delivery CD Bioparticles
17-Oct-2025 Creative Diagnostics Introduces OGN™ Tumor-derived Organoid Culture Kits to Advance Cancer Research Creative Diagnostics
17-Oct-2025 Beautinelle Launches BeneLift Pro: A Groundbreaking FDA-Approved Nano Infusion Device ACCESS Newswire
17-Oct-2025 Global Sports Medicine Market Expected to Achieve Robust Growth Momentum With 8% CAGR Over the Forecast Period Medi-Tech Insights
17-Oct-2025 Apheresis Market Expected to Grow At a CAGR of ~8% Driven By Increasing Prevalence Of Chronic And Autoimmune Diseases Medi-Tech Insights
16-Oct-2025 Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Businesswire
16-Oct-2025 Galapagos Announces Appointment of Fred Blakeslee as General Counsel Galapagos NV
16-Oct-2025 OKYO Pharma Announces Chairman and Founder Acquires Shares OKYO Pharma Limited
16-Oct-2025 Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting Microbot Medical Inc.
16-Oct-2025 Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds Theriva™ Biologics
16-Oct-2025 Positive Results from Clinical Pharmacokinetic Study for the Eosinophilic Esophagitis Specific Formulation with the Drug Candidate AQ280 Aqilion
16-Oct-2025 Syngene International invests in dedicated peptide laboratory and advanced automation Syngene
16-Oct-2025 Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives Businesswire
16-Oct-2025 EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies Businesswire
16-Oct-2025 The Solubility Company Announces New Licensing and Partnership Models for a Data­ Driven Era Businesswire
16-Oct-2025 Rosen Law Firm Urges MoonLake Immunotherapeutics (NASDAQ: MLTX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Businesswire
16-Oct-2025 Poxel Reports Financial Results for Full Year 2024 and Provides Operational and Financial Update Businesswire
16-Oct-2025 Poxel Reports Financial Results for Full Year 2024 and Provides Operational and Financial Update Businesswire